Safety evaluation of the food enzyme α-amylase from the genetically modified Bacillus amyloliquefaciens strain DP-Czb53
- PMID: 33144885
- PMCID: PMC7592075
- DOI: 10.2903/j.efsa.2020.6185
Safety evaluation of the food enzyme α-amylase from the genetically modified Bacillus amyloliquefaciens strain DP-Czb53
Abstract
The food enzyme α-amylase (4-α-d-glucan glucohydrolase; EC 3.2.1.1) is produced with the genetically modified B. amyloliquefaciens strain DP-Czb53 by Danisco US Inc. The genetic modifications do not raise safety concerns, except for the presence of a multicopy plasmid carrying known antimicrobial resistance genes. However, based on the absence of viable cells and DNA from the production organism in the food enzyme, this is not considered to be a risk. The food enzyme is intended to be used in starch processing for the production of glucose syrups. Toxicological studies and dietary exposure estimation were not considered necessary. Similarity of the amino acid sequence to those of known allergens was searched and one match was found. The Panel considered that, under the intended conditions of use, the risk of allergic sensitisation and elicitation reactions by dietary exposure cannot be excluded, but the likelihood for this to occur is considered to be low. Based on the data provided, the Panel concluded that this food enzyme does not give rise to safety concerns under the intended conditions of use.
Keywords: 1,4‐α‐d‐glucan glucanohydrolase; 4‐α‐d‐glucan glucanohydrolase; Bacillus amyloliquefaciens; EC 3.2.1.1; Food enzyme; genetically modified microorganism; α‐amylase.
© 2020 European Food Safety Authority. EFSA Journal published by John Wiley and Sons Ltd on behalf of European Food Safety Authority.
Similar articles
-
Safety evaluation of the food enzyme α-amylase from a genetically modified strain of Bacillus licheniformis (DP-Dzb54).EFSA J. 2019 Jan 10;17(1):e05549. doi: 10.2903/j.efsa.2019.5549. eCollection 2019 Jan. EFSA J. 2019. PMID: 32626094 Free PMC article.
-
Safety evaluation of the food enzyme α-amylase from Bacillus licheniformis (strain DP-Dzb44).EFSA J. 2019 Jun 14;17(6):e05738. doi: 10.2903/j.efsa.2019.5738. eCollection 2019 Jun. EFSA J. 2019. PMID: 32626356 Free PMC article.
-
Safety evaluation of the food enzyme α-amylase from the genetically modified Bacillus licheniformis strain DP-Dzb52.EFSA J. 2021 Apr 30;19(4):e06564. doi: 10.2903/j.efsa.2021.6564. eCollection 2021 Apr. EFSA J. 2021. PMID: 33968252 Free PMC article.
-
Safety evaluation of the food enzyme α-amylase from Bacillus amyloliquefaciens strain BANSC.EFSA J. 2020 Jan 20;18(1):e05976. doi: 10.2903/j.efsa.2020.5976. eCollection 2020 Jan. EFSA J. 2020. PMID: 32626506 Free PMC article.
-
Safety evaluation of the food enzyme alpha-amylase from a genetically modified Bacillus licheniformis (strain NZYM-AN).EFSA J. 2018 Jul 6;16(7):e05317. doi: 10.2903/j.efsa.2018.5317. eCollection 2018 Jul. EFSA J. 2018. PMID: 32625959 Free PMC article.
References
-
- Armentia A, Dias‐Perales A, Castrodeza J, Dueñas‐Laita A, Palacin A and Fernándes S, 2009. Why can patients with baker's asthma tolerate wheat flour ingestion? Is wheat pollen allergy relevant? Allergologia et Immunopathologia, 37, 203–204. - PubMed
-
- Baur X and Czuppon AB, 1995. Allergic reaction after eating alpha‐amylase (Asp o 2)‐containing bred. A case report. Allergy, 50, 85–87. - PubMed
-
- Cullinan P, Cook A, Jones M, Cannon J, Fitzgerald B and Newman Taylor AJ, 1997. Clinical responses to ingested fungal a‐amylase and hemicellulase in persons sensitized to Aspergillus fumigatus? Allergy, 52, 346–349. - PubMed
LinkOut - more resources
Full Text Sources